diabetes mellitus type 2/edema

Povezava se shrani v odložišče

Članki Kliničnih preskušanj Patenti

Izberite vrsto razvrščanja

Stran 1 iz 62 rezultatov

A Study That Uses Data From Routine Eye Examinations of Patients Participating in Studies FIDELIO-DKD and FIGARO-DKD to Explore Whether Finerenone Can Delay the Progression of a Diabetes Complication That Affects the Eyes (Diabetic Retinopathy ,DR)

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Outcomes of Subthreshold Laser Versus Intravitreal Injection of Ranibizumab in Diabetic Macular Edema

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Diabetic macular edema (DME) causes significant visual loss in diabetic patients. About 20% and 40% of patients with Type 1 and Type 2 diabetes mellitus (DM), respectively, develop DME. One-third of diabetic patients who have had DM for more than twenty years will develop DME . Early impairment in

Arterial Composition and Cardiovascular Outcome in DIabeteS

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

PhD project description The arterial wall in patients with diabetes: Do changes in arterial basement membrane proteins predict future arterial disease? Are remodeling processes altered? Applicant: Anne-Sofie Faarvang Thorsen1, MD Main supervisor: Professor Lars Melholt Rasmussen1 Co-supervisors:

Effectiveness of Foot Exercise People With Type 2 Diabetes

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Purpose of our study investigation of the effects foot exercises in patients with type 2 diabetic and peripheral neuropathy. Excepted results: Routine treatment + foot exercises pain, flexibility, edema, muscle strength, sensation, quality of life we believe that there will be good progress in

The Sensitivity of Traditional Chinese Medical Diagnostic Tools for Diabetic Retinopathy Diabetic retinopathy-a Pilot Study

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

GLP-1 REceptor Agonists and Real World EvIdeNce

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Introduction. Glucagon-like peptide-1 receptor agonists (GLP-1RA) are prioritized as a second-line therapy for the treatment of type 2 diabetes (T2D), especially in patients with a history of cardiovascular disease (CVD) or when there is a need to avoid weight gain and hypoglycemia. Randomized

Effects of Fenofibrate Therapy in Diabetic Nephropathy

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

In this single-centre, open label study, 300 adults with DN will be recruited over 3 years. Following screening and baseline metabolic evaluations, eligible subjects will be treated with fenofibrate for 30-days and re-assessed. 4.1 Study Visits and Procedures Subjects will have their written

Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer's Disease Prevention

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

As part of the central nervous system (CNS), the retina shares key structural and functional features with the brain, making it a potential portal into a patient's medical future. Since the cerebral and retinal microvasculature are strikingly similar, the condition of retinal vasculature has been

Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Diabetic Retinopathy (DR) is a frequent complication of Diabetes Mellitus (DM) and is the main cause of vision loss in the working population in western countries. Several studies provided evidence that good diabetic control is important to prevent and delay disease progression, but while some

Shanghai Beixinjing Diabetic Eyes Study

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

PROMINENT-Eye Ancillary Study (Protocol AD)

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Screening For Diabetic Macular Edema Among Diabetic Patients Using Optical Coherence Tomography

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

The worldwide prevalence of diabetic macular edema was reported as 6.81% among patients with diabetes. Other research reported that the 10-year incidence of diabetic macular edema was 14% in individuals with type 2 diabetes, and progression to diabetic macular edema occurred in 29% of individuals

Empagliflozin Reduces Progression of Diabetic Retinopathy in Patients With High Risk of Diabetic Macular Edema

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Safety and Exploratory Efficacy Study of SF0166 for the Treatment of Diabetic Macular Edema (DME)

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

This is a prospective, randomized, double-masked, multicenter, Phase I/II clinical study in which up to 40 eligible subjects with active Diabetic Macular Edema (DME) will be randomized to 1 of 2 treatment arms in a 1:1 ratio as follows: SF0166 low dose twice daily (BID) or SF0166 high dose BID. The

CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea

Samo registrirani uporabniki lahko prevajajo članke

Prijava / prijava

Prejšnji
1
2
3
4
5
Naslednji

Pridružite se naši
facebook strani

Herbal & Natural Medicine

Najbolj popolna baza zdravilnih zelišč, podprta z znanostjo

Deluje v 55 jezikih
Zeliščna zdravila, podprta z znanostjo
Prepoznavanje zelišč po sliki
Interaktivni GPS zemljevid - označite zelišča na lokaciji (kmalu)
Preberite znanstvene publikacije, povezane z vašim iskanjem
Iščite zdravilna zelišča po njihovih učinkih
Organizirajte svoje interese in bodite na tekočem z raziskavami novic, kliničnimi preskušanji in patenti

Vnesite simptom ali bolezen in preberite o zeliščih, ki bi lahko pomagala, vnesite zelišče in si oglejte bolezni in simptome, proti katerim se uporablja.
* Vse informacije temeljijo na objavljenih znanstvenih raziskavah